Post-approval studies (Phase 4)Study completedNCT00737711
What this trial is testing
Two-Weekly Intravenous Mircera for the Treatment of Dialysis Patients With Chronic Renal Anemia Not Receiving ESA Therapy.
Who this might be right for
Anemia
Hoffmann-La Roche 189